ArticleTuberculosis (Edinburgh, Scotland)2016

Formulation studies of InhA inhibitors and combination therapy to improve efficacy against Mycobacterium tuberculosis.

Susan E Knudson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.